160 related articles for article (PubMed ID: 12007883)
1. Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep.
Chen D; Colditz IG; Glenn GM; Tsonis CG
Vet Immunol Immunopathol; 2002 Jul; 86(3-4):177-82. PubMed ID: 12007883
[TBL] [Abstract][Full Text] [Related]
2. Induction of systemic immune responses in sheep by topical application of cholera toxin to skin.
Chen D; Colditz IG; Glenn GM; Tsonis CG
Vet Immunol Immunopathol; 2000 Dec; 77(3-4):191-9. PubMed ID: 11137118
[TBL] [Abstract][Full Text] [Related]
3. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.
Gockel CM; Bao S; Beagley KW
Mol Immunol; 2000 Jun; 37(9):537-44. PubMed ID: 11163403
[TBL] [Abstract][Full Text] [Related]
5. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
6. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Glenn GM; Scharton-Kersten T; Vassell R; Matyas GR; Alving CR
Infect Immun; 1999 Mar; 67(3):1100-6. PubMed ID: 10024549
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous immunization with phosphorylcholine induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Kurono Y
Auris Nasus Larynx; 2015 Dec; 42(6):478-82. PubMed ID: 26092312
[TBL] [Abstract][Full Text] [Related]
9. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
[TBL] [Abstract][Full Text] [Related]
10. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous immunization: T cell responses and boosting of existing immunity.
Hammond SA; Walwender D; Alving CR; Glenn GM
Vaccine; 2001 Mar; 19(17-19):2701-7. PubMed ID: 11257412
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.
Glenn GM; Scharton-Kersten T; Vassell R; Mallett CP; Hale TL; Alving CR
J Immunol; 1998 Oct; 161(7):3211-4. PubMed ID: 9759833
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
16. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
[TBL] [Abstract][Full Text] [Related]
17. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.
Simecka JW; Jackson RJ; Kiyono H; McGhee JR
Infect Immun; 2000 Feb; 68(2):672-9. PubMed ID: 10639432
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria.
Hirobe S; Matsuo K; Quan YS; Kamiyama F; Morito H; Asada H; Takaya Y; Mukai Y; Okada N; Nakagawa S
Vaccine; 2012 Feb; 30(10):1847-54. PubMed ID: 22230592
[TBL] [Abstract][Full Text] [Related]
19. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
20. The ovine nasal mucosa: an alternative tissue site for mucosal immunization.
Sedgmen BJ; Lofthouse SA; Meeusen EN
Methods; 2006 Feb; 38(2):112-6. PubMed ID: 16427306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
